RSAD1
gene geneOn this page
Also known as FLJ11164HemW
Summary
RSAD1 (radical S-adenosyl methionine domain containing 1, HGNC:25634) is a protein-coding gene on chromosome 17q21.33, encoding Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Q9HA92). May be a heme chaperone, appears to bind heme. It is a selective cancer dependency (DepMap: 17.3% of cell lines).
Enables heme binding activity. Predicted to be involved in porphyrin-containing compound biosynthetic process. Located in mitochondrion.
Source: NCBI Gene 55316 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 83 total
- Cancer dependency (DepMap): dependent in 17.3% of screened cell lines
- MANE Select transcript:
NM_018346
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25634 |
| Approved symbol | RSAD1 |
| Name | radical S-adenosyl methionine domain containing 1 |
| Location | 17q21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ11164, HemW |
| Ensembl gene | ENSG00000136444 |
| Ensembl biotype | protein_coding |
| OMIM | 620590 |
| Entrez | 55316 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 9 protein_coding, 3 retained_intron, 3 nonsense_mediated_decay
ENST00000258955, ENST00000443328, ENST00000504284, ENST00000506211, ENST00000509398, ENST00000510554, ENST00000513650, ENST00000515221, ENST00000859048, ENST00000859049, ENST00000859050, ENST00000859051, ENST00000859052, ENST00000926999, ENST00000943159
RefSeq mRNA: 1 — MANE Select: NM_018346
NM_018346
CCDS: CCDS11569
Canonical transcript exons
ENST00000258955 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000737052 | 50479880 | 50480084 |
| ENSE00001018465 | 50484744 | 50485974 |
| ENSE00003479450 | 50482091 | 50482456 |
| ENSE00003510924 | 50483340 | 50483487 |
| ENSE00003520720 | 50484442 | 50484545 |
| ENSE00003529405 | 50482643 | 50482706 |
| ENSE00003557993 | 50479629 | 50479762 |
| ENSE00003570893 | 50478860 | 50479019 |
| ENSE00003659243 | 50483706 | 50483760 |
Expression profiles
Bgee: expression breadth ubiquitous, 280 present calls, max score 97.33.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.0605 / max 135.4164, expressed in 1789 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161667 | 11.0236 | 1767 |
| 161666 | 3.6861 | 1568 |
| 161665 | 1.3508 | 870 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 97.33 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.23 | gold quality |
| cerebellar cortex | UBERON:0002129 | 97.11 | gold quality |
| body of pancreas | UBERON:0001150 | 96.15 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.94 | gold quality |
| cerebellum | UBERON:0002037 | 95.91 | gold quality |
| endocervix | UBERON:0000458 | 95.72 | gold quality |
| apex of heart | UBERON:0002098 | 95.50 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.89 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.86 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.77 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.77 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.71 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.70 | gold quality |
| body of stomach | UBERON:0001161 | 94.41 | gold quality |
| right ovary | UBERON:0002118 | 94.37 | gold quality |
| muscle of leg | UBERON:0001383 | 94.36 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.35 | gold quality |
| adrenal cortex | UBERON:0001235 | 94.33 | gold quality |
| left ovary | UBERON:0002119 | 94.13 | gold quality |
| right frontal lobe | UBERON:0002810 | 94.01 | gold quality |
| body of uterus | UBERON:0009853 | 93.96 | gold quality |
| thyroid gland | UBERON:0002046 | 93.62 | gold quality |
| right lobe of liver | UBERON:0001114 | 93.56 | gold quality |
| ectocervix | UBERON:0012249 | 93.55 | gold quality |
| adrenal gland | UBERON:0002369 | 93.50 | gold quality |
| heart left ventricle | UBERON:0002084 | 93.27 | gold quality |
| nucleus accumbens | UBERON:0001882 | 93.26 | gold quality |
| putamen | UBERON:0001874 | 93.18 | gold quality |
| right uterine tube | UBERON:0001302 | 92.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
46 targeting RSAD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-1976 | 99.74 | 65.48 | 1127 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-4728-3P | 99.47 | 68.94 | 981 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-519D-5P | 99.41 | 69.30 | 2057 |
| HSA-MIR-6853-3P | 99.36 | 70.79 | 1558 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-5693 | 99.24 | 66.67 | 1106 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-4451 | 98.82 | 68.17 | 1455 |
| HSA-MIR-6794-3P | 98.76 | 66.99 | 894 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-3145-5P | 98.57 | 67.83 | 900 |
| HSA-MIR-6824-3P | 98.44 | 67.62 | 1154 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 17.3% of screened cell lines.
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rsad1 | ENSDARG00000077698 |
| mus_musculus | Rsad1 | ENSMUSG00000039096 |
| rattus_norvegicus | Rsad1 | ENSRNOG00000065974 |
Protein
Protein identifiers
Radical S-adenosyl methionine domain-containing protein 1, mitochondrial — Q9HA92 (reviewed: Q9HA92)
Alternative names: Putative heme chaperone
All UniProt accessions (4): Q9HA92, H0Y934, H0Y9X4, K7EKD3
UniProt curated annotations — full annotation on UniProt →
Function. May be a heme chaperone, appears to bind heme. Homologous bacterial proteins do not have oxygen-independent coproporphyrinogen-III oxidase activity. Binds 1 [4Fe-4S] cluster. The cluster is coordinated with 3 cysteines and an exchangeable S-adenosyl-L-methionine.
Subcellular location. Mitochondrion.
Miscellaneous. Might carry two S-adenosyl-L-methionine binding sites with only one binding to the iron-sulfur cluster.
Similarity. Belongs to the anaerobic coproporphyrinogen-III oxidase family. HemW subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9HA92-1 | 1 | yes |
| Q9HA92-2 | 2 |
RefSeq proteins (1): NP_060816* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004559 | HemW-like | Family |
| IPR006638 | Elp3/MiaA/NifB-like_rSAM | Domain |
| IPR007197 | rSAM | Domain |
| IPR010723 | HemN_C | Domain |
| IPR013785 | Aldolase_TIM | Homologous_superfamily |
| IPR034505 | Coproporphyrinogen-III_oxidase | Family |
| IPR058240 | rSAM_sf | Homologous_superfamily |
Pfam: PF04055, PF06969
UniProt features (22 total): binding site 10, splice variant 3, sequence variant 3, sequence conflict 3, transit peptide 1, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HA92-F1 | 91.00 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (10): 158; 170; 195; 43; 49; 53; 56; 98; 99–100; 131
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (1): porphyrin-containing compound biosynthetic process (GO:0006779)
GO Molecular Function (6): coproporphyrinogen oxidase activity (GO:0004109), heme binding (GO:0020037), metal ion binding (GO:0046872), 4 iron, 4 sulfur cluster binding (GO:0051539), catalytic activity (GO:0003824), iron-sulfur cluster binding (GO:0051536)
GO Cellular Component (2): cytoplasm (GO:0005737), mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| porphyrin-containing compound metabolic process | 1 |
| tetrapyrrole biosynthetic process | 1 |
| oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 1 |
| tetrapyrrole binding | 1 |
| cation binding | 1 |
| iron-sulfur cluster binding | 1 |
| molecular_function | 1 |
| metal cluster binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
3019 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RSAD1 | TYW1 | Q9NV66 | 505 |
| RSAD1 | MOCS1 | Q9NZB8 | 490 |
| RSAD1 | PIGZ | Q86VD9 | 477 |
| RSAD1 | CDK5RAP1 | Q96SZ6 | 475 |
| RSAD1 | DPM3 | Q9P2X0 | 474 |
| RSAD1 | DPM2 | O94777 | 462 |
| RSAD1 | ELP3 | Q9H9T3 | 450 |
| RSAD1 | TMEM161A | Q9NX61 | 449 |
| RSAD1 | DPM1 | O60762 | 448 |
| RSAD1 | RSAD2 | Q8WXG1 | 444 |
| RSAD1 | METTL25B | Q96FB5 | 444 |
| RSAD1 | CZIB | Q9NWV4 | 435 |
| RSAD1 | GARRE1 | O15063 | 433 |
| RSAD1 | BOLA1 | Q9Y3E2 | 422 |
| RSAD1 | OR5H14 | A6NHG9 | 418 |
| RSAD1 | THNSL1 | Q8IYQ7 | 418 |
IntAct
63 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| NDUFS6 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.640 |
| BPNT1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| KLHDC2 | PFDN1 | psi-mi:“MI:0914”(association) | 0.530 |
| PNLIP | LAMC1 | psi-mi:“MI:0914”(association) | 0.530 |
| WDR53 | BLVRA | psi-mi:“MI:0914”(association) | 0.530 |
| ARHGEF26 | CPS1 | psi-mi:“MI:0914”(association) | 0.530 |
| WDR53 | NACAD | psi-mi:“MI:0914”(association) | 0.350 |
| TRMT1 | HDAC3 | psi-mi:“MI:0914”(association) | 0.350 |
| LIG3 | NDUFS6 | psi-mi:“MI:0914”(association) | 0.350 |
| SDHB | CLPX | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| MGARP | BTAF1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF460 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| UQCRFS1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| PTH2R | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| RTCA | NDUFA4 | psi-mi:“MI:0914”(association) | 0.350 |
| TRAV20 | MAP2K7 | psi-mi:“MI:0914”(association) | 0.350 |
| TRMU | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM43 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| QRSL1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| SHC2 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| YARS2 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPS24 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| AMACR | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| ACSM5 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| AK4 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (59): RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS)
ESM2 similar proteins: A4FV98, A5D7B1, A5PK51, A6QLN9, A8MUP2, D3ZVU9, O15527, O35595, O75078, O95848, P57775, Q05B60, Q06643, Q14728, Q14CX5, Q1LZB9, Q27HK4, Q2T9T5, Q2TBS1, Q3UGX3, Q4R3I0, Q4V892, Q58CT4, Q5E9H2, Q5RCI5, Q5SUV1, Q5TM22, Q642A6, Q6IA17, Q6PCB0, Q6XQN6, Q862Z7, Q8N8L6, Q8R2R5, Q8R2Z5, Q8R366, Q8WUG5, Q95JH0, Q95JH2, Q969P0
Diamond homologs: A4IGH2, A5D7B1, P43899, P52062, P54304, P73245, P95506, P9WP72, P9WP73, Q54VE8, Q5SUV1, Q8K928, Q9HA92, O34162, P57615, P77915, O67886, P0A1E1, P0A1E2, P32131, P74132, Q89A47, Q9CGF7, Q51676, O31381, P33770, P55477, P95651, Q796V8, O25376, O31067, O59545, P51008, Q9ZLH0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
83 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1656 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:50479020:G:GG | donor_gain | 1.0000 |
| 17:50479627:A:AG | acceptor_gain | 1.0000 |
| 17:50479627:AGT:A | acceptor_gain | 1.0000 |
| 17:50479628:G:GG | acceptor_gain | 1.0000 |
| 17:50479628:GT:G | acceptor_gain | 1.0000 |
| 17:50479628:GTG:G | acceptor_gain | 1.0000 |
| 17:50479759:AACGG:A | donor_loss | 1.0000 |
| 17:50479761:CGG:C | donor_loss | 1.0000 |
| 17:50479762:GGT:G | donor_loss | 1.0000 |
| 17:50479763:G:T | donor_loss | 1.0000 |
| 17:50479989:G:GT | donor_gain | 1.0000 |
| 17:50482089:A:AG | acceptor_gain | 1.0000 |
| 17:50482090:G:GG | acceptor_gain | 1.0000 |
| 17:50482452:GGAAT:G | donor_gain | 1.0000 |
| 17:50482453:GAAT:G | donor_gain | 1.0000 |
| 17:50482453:GAATG:G | donor_gain | 1.0000 |
| 17:50482454:A:T | donor_gain | 1.0000 |
| 17:50482457:G:GG | donor_gain | 1.0000 |
| 17:50482457:GTAA:G | donor_loss | 1.0000 |
| 17:50482458:T:G | donor_loss | 1.0000 |
| 17:50483485:GCT:G | donor_gain | 1.0000 |
| 17:50478967:G:GT | donor_gain | 0.9900 |
| 17:50479015:TACAC:T | donor_gain | 0.9900 |
| 17:50479018:AC:A | donor_gain | 0.9900 |
| 17:50479018:ACGT:A | donor_loss | 0.9900 |
| 17:50479020:G:GC | donor_loss | 0.9900 |
| 17:50479021:TGA:T | donor_loss | 0.9900 |
| 17:50479022:GAGTA:G | donor_loss | 0.9900 |
| 17:50479023:AGT:A | donor_loss | 0.9900 |
| 17:50479620:T:A | acceptor_gain | 0.9900 |
AlphaMissense
2800 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:50479665:T:C | F58L | 0.996 |
| 17:50479667:C:A | F58L | 0.996 |
| 17:50479667:C:G | F58L | 0.996 |
| 17:50480065:G:T | R152M | 0.994 |
| 17:50482701:G:A | G300E | 0.994 |
| 17:50479893:T:C | F95L | 0.993 |
| 17:50479895:C:A | F95L | 0.993 |
| 17:50479895:C:G | F95L | 0.993 |
| 17:50479914:A:C | S102R | 0.993 |
| 17:50479916:T:A | S102R | 0.993 |
| 17:50479916:T:G | S102R | 0.993 |
| 17:50483422:G:C | W329C | 0.992 |
| 17:50483422:G:T | W329C | 0.992 |
| 17:50479660:G:A | C56Y | 0.991 |
| 17:50479629:T:A | W46R | 0.990 |
| 17:50479629:T:C | W46R | 0.990 |
| 17:50479017:C:G | H45D | 0.989 |
| 17:50480003:G:C | E131D | 0.989 |
| 17:50480003:G:T | E131D | 0.989 |
| 17:50482445:T:C | F277L | 0.989 |
| 17:50482447:T:A | F277L | 0.989 |
| 17:50482447:T:G | F277L | 0.989 |
| 17:50483420:T:A | W329R | 0.989 |
| 17:50483420:T:C | W329R | 0.989 |
| 17:50482444:C:A | N276K | 0.988 |
| 17:50482444:C:G | N276K | 0.988 |
| 17:50482652:A:C | S284R | 0.988 |
| 17:50482654:T:A | S284R | 0.988 |
| 17:50482654:T:G | S284R | 0.988 |
| 17:50479639:G:A | C49Y | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000136382 (17:50479538 AGGGGTG>A,AGGGGTGGGGGTG), RS1000176049 (17:50481556 T>C), RS1000580099 (17:50479839 A>C), RS1000696835 (17:50481310 C>G,T), RS1001075304 (17:50485672 C>G,T), RS1001320411 (17:50484205 G>T), RS1001556946 (17:50480546 G>A), RS1001598676 (17:50479265 T>C), RS1001777657 (17:50480847 C>T), RS1001964726 (17:50485133 C>A,T), RS1002324793 (17:50477757 G>T), RS1003063199 (17:50478105 C>A,T), RS1003792216 (17:50478333 G>A), RS1004390154 (17:50479819 G>A,C,T), RS1004712025 (17:50484742 A>G)
Disease associations
OMIM: gene MIM:620590 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression, increases expression | 2 |
| Cisplatin | affects cotreatment, increases expression, decreases expression | 2 |
| Valproic Acid | increases expression, affects expression | 2 |
| pirinixic acid | affects binding, increases activity, increases expression | 1 |
| trichostatin A | increases expression | 1 |
| methylparaben | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Selenium | increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vitamin E | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TJ80 | HAP1 RSAD1 (-) 1 | Cancer cell line | Male |
| CVCL_XS32 | HAP1 RSAD1 (-) 2 | Cancer cell line | Male |
| CVCL_XS33 | HAP1 RSAD1 (-) 3 | Cancer cell line | Male |
| CVCL_XS34 | HAP1 RSAD1 (-) 4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.